Immediate effects of individualized heparin and protamine management on hemostatic activation and platelet function in adult patients undergoing cardiac surgery with tranexamic acid antifibrinolytic therapy

Perfusion (United Kingdom)

Volumn 28, Issue 5, 2013, Pages 412-418

  Hofmann, B ^a   Bushnaq, H ^a   Kraus, F B ^b   Raspe C ^b   Simm, A ^a   Silber, R E ^a   Ludwig Kraus, B ^b  

^a MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

cardiac surgery; coagulation; individualized heparin and protamine dosing; platelet function

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBIN; CLOPIDOGREL; FENTANYL; FRESH FROZEN PLASMA; HEPARIN; PANCURONIUM BROMIDE; PROPOFOL; PROTAMINE SULFATE; THROMBIN; THROMBIN ANTITHROMBIN COMPLEX; THROMBOCYTE CONCENTRATE; TRANEXAMIC ACID; WARFARIN;

AGED; ANTICOAGULANT THERAPY; ARTERIAL FILTER; ARTICLE; BLEEDING; BLOOD CLOTTING PARAMETERS; BLOOD CLOTTING TEST; BLOOD SAMPLING; BLOOD TRANSFUSION; BODY MASS; CARDIOPULMONARY BYPASS; CARDIOPULMONARY BYPASS EQUIPMENT; CLAMP; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY BYPASS SURGERY; DOSE RESPONSE; ELECTIVE SURGERY; ERYTHROCYTE; EXTRACORPOREAL CIRCULATION; FEMALE; FLOW RATE; HEART SURGERY; HEMATOCRIT; HEMOSTASIS; HEPARINIZATION; HOLLOW FIBER MEMBRANE; HUMAN; INTERNATIONAL NORMALIZED RATIO; MALE; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINE; PRESERVATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION;

CARDIAC SURGERY; COAGULATION; INDIVIDUALIZED HEPARIN AND PROTAMINE DOSING; PLATELET FUNCTION;

ADULT; AGED; ANTIFIBRINOLYTIC AGENTS; BLOOD COAGULATION; BLOOD PLATELETS; CORONARY ARTERY BYPASS; FEMALE; FIBRINOLYTIC AGENTS; HEPARIN; HEPARIN ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; PLATELET ACTIVATION; PROSPECTIVE STUDIES; PROTAMINES; TRANEXAMIC ACID;

EID: 84882943891     PISSN: 02676591     EISSN: 1477111X     Source Type: Journal    
DOI: 10.1177/0267659113483800     Document Type: Article

References (23)

1. Ferguson TB, Hammill BG, Peterson ED, DeLong ER, Grover FL. A decade of change -risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990-1999: a report from the STS National Database Committee and the Duke Clinical Research Institute. Society of Thoracic Surgeons. Ann Thorac Surg. 2002 ; 73: 480-489
2. Friedrich I, Simm A, Kotting J, Tholen F, Fischer B, Silber RE. Cardiac surgery in the elderly patient. Dtsch Arztebl Int. 2009 ; 106: 416-422
3. Karkouti K, Wijeysundera DN, Yau TM, et al. The independent association of massive blood loss with mortality in cardiac surgery. Transfusion. 2004 ; 44: 1453-1462
4. Hattersley PG. Activated coagulation time of whole blood. JAMA. 1966 ; 196: 436-440
5. Bull BS, Huse WM, Brauer FS, Korpman RA. Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage. J Thorac Cardiovasc Surg. 1975 ; 69: 685-689
6. Hattersley PG. Progress report: the activated coagulation time of whole blood (ACT). Am J Clin Pathol. 1976 ; 66: 899-904
7. Babka R, Colby C, El-Etr A, Pifarre R. Monitoring of intraoperative heparinization and blood loss following cardiopulmonary bypass surgery. J Thorac Cardiovasc Surg. 1977 ; 73: 780-782
8. Culliford AT, Gitel SN, Starr N, et al. Lack of correlation between activated clotting time and plasma heparin during cardiopulmonary bypass. Ann Surg. 1981 ; 193: 105-111
9. Despotis GJ, Gravlee G, Filos K, Levy J. Anticoagulation monitoring during cardiac surgery: a review of current and emerging techniques. Anesthesiology. 1999 ; 91: 1122-1151
10. Koster A, Fischer T, Praus M, et al. Hemostatic activation and inflammatory response during cardiopulmonary bypass: impact of heparin management. Anesthesiology. 2002 ; 97: 837-841
11. Koster A, Huebler S, Merkle F, et al. Heparin-level-based anticoagulation management during cardiopulmonary bypass: a pilot investigation on the effects of a half-dose aprotinin protocol on postoperative blood loss and hemostatic activation and inflammatory response. Anesth Analg. 2004 ; 98: 285-290
12. Guzzetta NA, Bajaj T, Fazlollah T, et al. A comparison of heparin management strategies in infants undergoing cardiopulmonary bypass. Anesth Analg. 2008 ; 106: 419-425
13. Khan NU, Wayne CK, Barker J, Strang T. The effects of protamine overdose on coagulation parameters as measured by the thrombelastograph. Eur J Anaesthesiol. 2010 ; 27: 624-627
14. Aziz KA, Masood O, Hoschtitzky JA, Ronald A. Does use of the Hepcon point-of-care coagulation monitor to optimise heparin and protamine dosage for cardiopulmonary bypass decrease bleeding and blood and blood product requirements in adult patients undergoing cardiac surgery?. Interact Cardiovasc Thorac Surg. 2006 ; 5: 469-482
15. Pappalardo F, Franco A, Crescenzi G, De Simone F, Torracca L, Zangrillo A. Anticoagulation management in patients undergoing open heart surgery by activated clotting time and whole blood heparin concentration. Perfusion. 2006 ; 21: 285-290
16. Fitzgerald DJ, Patel A, Body SC, Garvin S. The relationship between heparin level and activated clotting time in the adult cardiac surgery population. Perfusion. 2009 ; 24: 93-96
17. Garvin S, FitzGerald DC, Despotis G, Shekar P, Body SC. Heparin concentration-based anticoagulation for cardiac surgery fails to reliably predict heparin bolus dose requirements. Anesth Analg. 2010 ; 111: 849-855
18. Calafiore AM, Teodori G, Mezzetti A, et al. Intermittent antegrade warm blood cardioplegia. Ann Thorac Surg. 1995 ; 59: 398-402
19. Cross-Sectional Guidelines for Therapy with Blood Components and Plasma Derivates - 4th revised edition. Transfus Med Hemother. 2009 ; 36: 345-492
20. Hoppe JD, Scriba PC, Kluter H. Cross-Sectional Guidelines for Therapy with Blood Components and Plasma Derivatives (4th revised edition, 2008) - Suspension of Chapter 5 'Human Albumin'. Transfus Med Hemother. 2011 ; 38: 71
21. Velik-Salchner C, Maier S, Innerhofer P, et al. An assessment of cardiopulmonary bypass-induced changes in platelet function using whole blood and classical light transmission aggregometry: the results of a pilot study. Anesth Analg. 2009 ; 108: 1747-1754
22. Shigeta O, Kojima H, Hiramatsu Y, et al. Low-dose protamine based on heparin-protamine titration method reduces platelet dysfunction after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1999 ; 118: 354-360
23. Slaughter TF, LeBleu TH, Douglas JM, Leslie JB, Parker JK, Greenberg CS. Characterization of prothrombin activation during cardiac surgery by hemostatic molecular markers. Anesthesiology. 1994 ; 80: 520-526